# EXoPERT EMERALD Clinical Study

> **NCT07186296** · — · RECRUITING · sponsor: **EXoPERT** · enrollment: 1400 (estimated)

## Conditions studied

- Breast Cancer
- Colon Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** EXoPred

## Key facts

- **NCT ID:** NCT07186296
- **Lead sponsor:** EXoPERT
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186296, "EXoPERT EMERALD Clinical Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07186296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*